Xeris Biopharma Holdings, Inc. · NASDAQ:XERS
Bormann-Kennedy Barbara-Jean Anne sold 16,000 Xeris Biopharma Holdings, Inc. shares (Form 4)
Traded Jun 4, 2026 · Filed Jun 5, 2026
On Jun 4, 2026, Bormann-Kennedy Barbara-Jean Anne (Director) sold 16,000 Xeris Biopharma Holdings, Inc. shares at US$6.09 for US$97,440 under a trading plan, leaving 150,693 shares. Filed Jun 5, 2026 (Form 4).
- Sold
- 16,000 shares
- Price
- US$6.09
- Value
- US$97,440
- Holding after
- 150,693 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | Sale | 16,000 | US$6.09 | 126,500 | Direct |
| Jun 4, 2026 | Common Stock | Award | 24,193 | 150,693 | Direct |